The AI revolution: how multimodal intelligence will reshape the oncology ecosystem

Abstract

Multimodal artificial intelligence (MMAI) is redefining oncology by integrating heterogeneous datasets from diagnostic modalities into cohesive analytical frameworks for more accurate and personalized cancer care. We highlight MMAI applications across the patient journey and clinical research, discuss outstanding challenges, and the need for guidelines and regulatory frameworks. By converting multimodal complexity into clinically actionable insights, MMAI is poised to improve patient outcomes while reshaping the economics of global cancer care.